News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cancer Prevention and Research Institute of Texas Awards Pulmotect $7.1 Million to Develop Novel Immune System Stimulant


5/9/2012 10:25:00 AM

HOUSTON--(BUSINESS WIRE)--Pulmotect, Inc. (www.pulmotect.com), a Houston-based biotechnology company, has been awarded $7.1 million by the Cancer Prevention & Research Institute of Texas (CPRIT) to advance its novel product, PUL-042, which offers the promise of better protecting patients receiving chemotherapy from infection, allowing for significantly higher treatment success. This award, when matched with the Company’s other funding, should allow the Company’s lead product to progress through preclinical, Phase I and Phase II trials.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES